HeartSciences (HSCSW) Change in Receivables (2022 - 2025)
HeartSciences posted quarterly Change in Receivables of -$4350.0 for Q3 2025, down 200.0% on a QoQ basis from $4350.0 in Q2 2025.
HeartSciences (HSCSW) has 3 years of Change in Receivables data on file, last reported at -$4350.0 in Q3 2025.
- For the quarter ending Q3 2025, Change in Receivables changed N/A year-over-year to -$4350.0; the trailing twelve-month figure through Oct 2025 stood at $10800.0 (changed N/A YoY), and the FY2025 full-year result was $4350.0, changed N/A from the prior year.
- Change in Receivables for Q3 2025 stood at -$4350.0, down from $4350.0 in the prior quarter.
- Across five years, Change in Receivables topped out at $10800.0 in Q1 2024 and bottomed at -$4350.0 in Q3 2025.
- The 3-year median for Change in Receivables is $1014.5 (2022), against an average of $2119.8.
Peer Comparison
| # | Company | Market Cap | Enterprise Value | Gross Profit (Qtr) | Change in Receivables (Qtr) |
|---|---|---|---|---|---|
| 1 | Abbott Laboratories | 152.82 Bn | 146.17 Bn | 6.27 Bn | 42.00 Mn |
| 2 | Stryker | 115.07 Bn | 112.19 Bn | 3.81 Bn | -444.00 Mn |
| 3 | Medtronic | 95.25 Bn | 87.08 Bn | 5.76 Bn | -13.00 Mn |
| 4 | Boston Scientific | 71.38 Bn | 70.17 Bn | 3.61 Bn | 117.00 Mn |
| 5 | Edwards Lifesciences | 51.08 Bn | 47.41 Bn | 1.29 Bn | 117.90 Mn |
| 6 | Koninklijke Philips | 29.38 Bn | 26.07 Bn | 2.07 Bn | - |
| 7 | Dexcom | 28.84 Bn | 27.72 Bn | 750.30 Mn | -124.60 Mn |
| 8 | GE HealthCare Technologies | 28.56 Bn | 26.49 Bn | 1.98 Bn | -141.00 Mn |
| 9 | Steris | 20.71 Bn | 20.30 Bn | 697.10 Mn | 123.50 Mn |
| 10 | HeartSciences | - | - | - | - |
Historic Data
Download Data| Date | Value |
|---|---|
| Jul 31, 2025 | -4,350.00 |
| Jul 31, 2025 | -4,350.00 |
| Apr 30, 2025 | 4,350.00 |
| Apr 30, 2025 | 4,350.00 |
| Jan 31, 2024 | 10,800.00 |
| Jan 31, 2024 | 10,800.00 |
| Jul 31, 2022 | -2,321.00 |
| Jul 31, 2022 | -2,321.00 |